Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and…
Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen device to improve affordability…
Zydus Lifesciences reported a 2% rise in Q3FY26 profit to Rs 1,042 crore, while revenue jumped 30% YoY to Rs…
Zydus Lifesciences has launched VaxiFlu, India’s first trivalent influenza vaccine for seasonal flu protection. The vaccine follows WHO’s 2025–26 guidelines…
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…
Torrent Pharma will emerge among the top 5 domestic pharma players by sales with the acquisition of J B Chemicals…
Discover why Jio Financial, Vodafone Idea, and 6 other stocks are in focus today – explore the market moves and…
Nuvama downgrades Zydus Lifesciences: Nuvama predicts a 10% drop in Zydus Lifesciences’ stock; explore the reasons now!
Zydus Lifesciences plans to acquire US-based Agenus Inc, entering the global biologics CDMO market with two California facilities. The deal…
Top trending stocks today, May 21: Indian equity indices fall for third day; explore top-performing stocks amidst the downturn.
Zydus Lifesciences posted Q4 profit at Rs 1,170.90 crore, marginally lower than Rs 1182.30 crore recorded during the corresponding quarter…
Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!
Pharma stocks surge as Trump’s tariff exemption boosts sector morale. Dive into this bullish trend today!
Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.
Zydus Lifesciences share price today, March 19: Zydus soars on US FDA approval for Apalutamide tablets. Discover the impact!
Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!
Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical technology.…
Amplitude Surgical has experienced significant growth over the last four years, driven by new product development, international growth, investments in…